Inhibition of the Mitochondrial Enzyme ABAD Restores the Amyloid-β-Mediated Deregulation of Estradiol

被引:47
作者
Lim, Yun-An [1 ]
Grimm, Amandine [2 ]
Giese, Maria [2 ]
Mensah-Nyagan, Ayikoe Guy [3 ]
Villafranca, J. Ernest [4 ]
Ittner, Lars M. [1 ]
Eckert, Anne [2 ]
Goetz, Juergen [1 ]
机构
[1] Univ Sydney, Alzheimers & Parkinsons Dis Lab, Brain & Mind Res Inst, Camperdown, NSW, Australia
[2] Univ Basel, Neurobiol Lab, Psychiat Univ Clin Basel, Basel, Switzerland
[3] Univ Strasbourg, Equipe Steroides Neuromodulateurs & Neuropathol, Strasbourg, France
[4] Villafranca Consulting, San Diego, CA USA
基金
澳大利亚研究理事会; 澳大利亚国家健康与医学研究理事会; 瑞士国家科学基金会;
关键词
TAU TRANSGENIC MICE; ALCOHOL-DEHYDROGENASE ABAD; COENZYME-A DEHYDROGENASE; DISEASE MOUSE MODEL; ALZHEIMERS-DISEASE; METABOLIC DYSFUNCTION; DIABETES-MELLITUS; BINDING; TOXICITY; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE;
D O I
10.1371/journal.pone.0028887
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Alzheimer's disease (AD) is a conformational disease that is characterized by amyloid-beta (A beta) deposition in the brain. A beta exerts its toxicity in part by receptor-mediated interactions that cause down-stream protein misfolding and aggregation, as well as mitochondrial dysfunction. Recent reports indicate that A beta may also interact directly with intracellular proteins such as the mitochondrial enzyme ABAD (A beta binding alcohol dehydrogenase) in executing its toxic effects. Mitochondrial dysfunction occurs early in AD, and A beta's toxicity is in part mediated by inhibition of ABAD as shown previously with an ABAD decoy peptide. Here, we employed AG18051, a novel small ABAD-specific compound inhibitor, to investigate the role of ABAD in A beta toxicity. Using SH-SY5Y neuroblastoma cells, we found that AG18051 partially blocked the A beta-ABAD interaction in a pull-down assay while it also prevented the A beta 42-induced down-regulation of ABAD activity, as measured by levels of estradiol, a known hormone and product of ABAD activity. Furthermore, AG18051 is protective against A beta 42 toxicity, as measured by LDH release and MTT absorbance. Specifically, AG18051 reduced A beta 42-induced impairment of mitochondrial respiration and oxidative stress as shown by reduced ROS (reactive oxygen species) levels. Guided by our previous finding of shared aspects of the toxicity of A beta and human amylin (HA), with the latter forming aggregates in Type 2 diabetes mellitus (T2DM) pancreas, we determined whether AG18051 would also confer protection from HA toxicity. We found that the inhibitor conferred only partial protection from HA toxicity indicating distinct pathomechanisms of the two amyloidogenic agents. Taken together, our results present the inhibition of ABAD by compounds such as AG18051 as a promising therapeutic strategy for the prevention and treatment of AD, and suggest levels of estradiol as a suitable readout.
引用
收藏
页数:12
相关论文
共 68 条
[1]   Signaling of reactive oxygen and nitrogen species in diabetes mellitus [J].
Afanas'ev, Igor .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2010, 3 (06) :361-373
[2]   Mitochondrial and nonmitochondrial reduction of MTT: Interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes [J].
Bernas, T ;
Dobrucki, J .
CYTOMETRY, 2002, 47 (04) :236-242
[3]   Mitochondrial β-amyloid in Alzheimer's disease [J].
Borger, Eva ;
Aitken, Laura ;
Muirhead, Kirsty E. A. ;
Allen, Zoe E. ;
Ainge, James A. ;
Conway, Stuart J. ;
Gunn-Moore, Frank J. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 :868-873
[4]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[5]   Mitochondrial membrane potential and hydroethidine-monitored superoxide generation in cultured cerebellar granule cells [J].
Budd, SL ;
Castilho, RF ;
Nicholls, DG .
FEBS LETTERS, 1997, 415 (01) :21-24
[6]   Delineating the mechanism of Alzheimer's disease Aβ peptide neurotoxicity [J].
Cappai, Roberto ;
Barnham, Kevin J. .
NEUROCHEMICAL RESEARCH, 2008, 33 (03) :526-532
[7]   Mitochondrial Aβ:: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease [J].
Caspersen, C ;
Wang, N ;
Yao, J ;
Sosunov, A ;
Chen, X ;
Lustbader, JW ;
Xu, HW ;
Stern, D ;
McKhann, G ;
Yan, SD .
FASEB JOURNAL, 2005, 19 (12) :2040-+
[8]   Mitochondrial Aβ:: A potential cause of metabolic dysfunction in Alzheimer's disease [J].
Chen, Xi ;
Yan, Shi Du .
IUBMB LIFE, 2006, 58 (12) :686-694
[9]   Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1-42 [J].
Crouch, PJ ;
Blake, R ;
Duce, JA ;
Ciccotosto, GD ;
Li, QX ;
Barnham, KJ ;
Curtain, CC ;
Cherny, RA ;
Cappai, R ;
Dyrks, T ;
Masters, CL ;
Trounce, IA .
JOURNAL OF NEUROSCIENCE, 2005, 25 (03) :672-679
[10]   Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease [J].
D'Amelio, Marcello ;
Cavallucci, Virve ;
Middei, Silvia ;
Marchetti, Cristina ;
Pacioni, Simone ;
Ferri, Alberto ;
Diamantini, Adamo ;
De Zio, Daniela ;
Carrara, Paolo ;
Battistini, Luca ;
Moreno, Sandra ;
Bacci, Alberto ;
Ammassari-Teule, Martine ;
Marie, Helene ;
Cecconi, Francesco .
NATURE NEUROSCIENCE, 2011, 14 (01) :69-U97